Brinker Capital Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-11,671
Closed -$1.93M 1470
2021
Q3
$1.93M Hold
11,671
0.03% 557
2021
Q2
$1.93M Sell
11,671
-2,123
-15% -$354K 0.03% 610
2021
Q1
$2.12M Sell
13,794
-77,402
-85% -$10.5M 0.03% 494
2020
Q4
$11.4M Buy
91,196
+54,266
+147% +$6.07M 0.18% 123
2020
Q3
$3.75M Buy
+36,930
New +$3.77M 0.06% 298

Brinker Capital Investments's PRAH Position: Q4 2021 in Review

Brinker Capital Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2021, closing a stake of 11,671 shares — an estimated $1.93M sold.

Brinker Capital Investments first reported a position in PRAH in Q3 2020 and held it in 5 quarters. The position peaked at $11.4M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRAH as of Q4 2021.

  • Brinker Capital Investments reported no remaining PRA Health Sciences, Inc. position as of Q4 2021 after selling out during the quarter.
  • Brinker Capital Investments sold 11,671 PRA Health Sciences, Inc. shares in Q4 2021, an estimated $1.93M.
  • Brinker Capital Investments first reported a position in PRA Health Sciences, Inc. in Q3 2020 and held it in 5 quarters.
  • Brinker Capital Investments's PRA Health Sciences, Inc. position peaked at $11.4M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2021.

Based on Brinker Capital Investments's 13F filing for Q4 2021, filed 8 Feb 2022.